Open Beta
MetriLume

US marketsCSBR

SEC-sourced researchBeta

CSBR

CHAMPIONS ONCOLOGY, INC.

Company comparison ↗

Data passport

CIK
0000771856
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Sep 11, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: April 2024: 50,155,000.0000 USD; April 2025: 56,944,000.0000 USD56.9M USD0 USD0April 2024April 2025
CSBR · Exact amounts and source periods · USD
Period endRevenueFiling date
April 202450,155,000.0000Jul 23, 2025
April 202556,944,000.0000Jul 23, 2025

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
April 202556,944,000.00004,701,000.00007,386,000.000032,344,000.000028,572,000.0000Jul 23, 2025
April 202450,155,000.0000-7,276,000.0000-6,137,000.000026,132,000.000028,035,000.0000Jul 23, 2025

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$56.94MApril 2025Jul 23, 202510-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$50.16MApril 2024Jul 23, 202510-K
Net incomeNetIncomeLoss$4.7MApril 2025Jul 23, 202510-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$7.39MApril 2025Jul 23, 202510-K
Total assetsAssets$32.34MApril 2025Jul 23, 202510-K
Total liabilitiesLiabilities$28.57MApril 2025Jul 23, 202510-K

New filings

Explore methodology ↗